Garrido A, Machhar R, Cruz-Correa O, Ganatra D, Crome S, Wither J
Front Immunol. 2025; 16:1483393.
PMID: 39991156
PMC: 11842318.
DOI: 10.3389/fimmu.2025.1483393.
Coates M, Richoz N, Tuong Z, Bowyer G, Lee C, Ferdinand J
Nat Immunol. 2025; 26(2):215-229.
PMID: 39890933
PMC: 11785532.
DOI: 10.1038/s41590-024-02064-9.
Feng X, Huo M, Li H, Yang Y, Jiang Y, He L
Brief Bioinform. 2025; 26(1).
PMID: 39883514
PMC: 11781202.
DOI: 10.1093/bib/bbaf030.
Yang J, Cali Daylan A, Shevkoplias A, Postovalova E, Wang M, Tyshevich A
Cells. 2025; 14(2).
PMID: 39851562
PMC: 11764145.
DOI: 10.3390/cells14020134.
Snyder T, Gittelman R, Klinger M, May D, Osborne E, Taniguchi R
Front Immunol. 2025; 15():1488860.
PMID: 39840037
PMC: 11747429.
DOI: 10.3389/fimmu.2024.1488860.
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires.
Braun J, Hill E, Contreras E, Yasuda M, Morgan A, Ditelberg S
bioRxiv. 2025; .
PMID: 39829775
PMC: 11741250.
DOI: 10.1101/2023.09.08.556703.
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma.
Monberg T, Kudling T, Albieri B, Pakola S, Ellebaek E, Donia M
Immunooncol Technol. 2025; 24():100726.
PMID: 39801682
PMC: 11725143.
DOI: 10.1016/j.iotech.2024.100726.
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes.
Zornikova K, Dianov D, Ivanova N, Davydova V, Nenasheva T, Fefelova E
Int J Mol Sci. 2024; 25(23).
PMID: 39684303
PMC: 11641755.
DOI: 10.3390/ijms252312591.
Single-cell analysis reveals expanded CD8 T cells in CSF and shared peripheral clones in sporadic amyotrophic lateral sclerosis.
Kim H, Ban J, Kang J, Im H, Ko S, Sung J
Brain Commun. 2024; 6(6):fcae428.
PMID: 39659975
PMC: 11631212.
DOI: 10.1093/braincomms/fcae428.
MR1 presents vitamin B6-related compounds for recognition by MR1-reactive T cells.
McInerney M, Awad W, Souter M, Kang Y, Wang C, Chan Yew Poa K
Proc Natl Acad Sci U S A. 2024; 121(49):e2414792121.
PMID: 39589872
PMC: 11626183.
DOI: 10.1073/pnas.2414792121.
tcrBLOSUM: an amino acid substitution matrix for sensitive alignment of distant epitope-specific TCRs.
Postovskaya A, Vercauteren K, Meysman P, Laukens K
Brief Bioinform. 2024; 26(1).
PMID: 39576224
PMC: 11583439.
DOI: 10.1093/bib/bbae602.
A modular protein language modelling approach to immunogenicity prediction.
OBrien H, Salm M, Morton L, Szukszto M, OFarrell F, Boulton C
PLoS Comput Biol. 2024; 20(11):e1012511.
PMID: 39527593
PMC: 11581412.
DOI: 10.1371/journal.pcbi.1012511.
The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients.
Zhou D, Luo Y, Ma Q, Xu Y, Yao X
Virulence. 2024; 15(1):2421987.
PMID: 39468707
PMC: 11540089.
DOI: 10.1080/21505594.2024.2421987.
The molecular mechanisms of CD8 T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions.
Deng S, Xu Z, Hu J, Yang Y, Zhu F, Liu Z
Front Immunol. 2024; 15:1468456.
PMID: 39450171
PMC: 11499136.
DOI: 10.3389/fimmu.2024.1468456.
Interpretable GWAS by linking clinical phenotypes to quantifiable immune repertoire components.
Tan Y, Wang L, Zhang H, Pan M, Liu D, Zhan X
Commun Biol. 2024; 7(1):1357.
PMID: 39428403
PMC: 11491462.
DOI: 10.1038/s42003-024-07010-x.
TIL Therapy in Lung Cancer: Current Progress and Perspectives.
Hu W, Bian Y, Ji H
Adv Sci (Weinh). 2024; 11(46):e2409356.
PMID: 39422665
PMC: 11633538.
DOI: 10.1002/advs.202409356.
Limits on inferring T cell specificity from partial information.
Henderson J, Nagano Y, Milighetti M, Tiffeau-Mayer A
Proc Natl Acad Sci U S A. 2024; 121(42):e2408696121.
PMID: 39374400
PMC: 11494314.
DOI: 10.1073/pnas.2408696121.
TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing.
Pogorelyy M, Kirk A, Adhikari S, Minervina A, Sundararaman B, Vegesana K
bioRxiv. 2024; .
PMID: 39345544
PMC: 11430070.
DOI: 10.1101/2024.09.16.613345.
SARS-CoV-2-specific CD8 T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.
Rowntree L, Audsley J, Allen L, McQuilten H, Hagen R, Chaurasia P
Proc Natl Acad Sci U S A. 2024; 121(39):e2411428121.
PMID: 39284068
PMC: 11441481.
DOI: 10.1073/pnas.2411428121.
Worse Wilms' Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs.
Rigby K, Diaz M, Gozlan E, Kacsoh D, Song J, Hudock T
Cancer Genomics Proteomics. 2024; 21(5):439-447.
PMID: 39191494
PMC: 11363928.
DOI: 10.21873/cgp.20462.
